Page last updated: 2024-09-05

erlotinib hydrochloride and Gastroduodenal Ulcer

erlotinib hydrochloride has been researched along with Gastroduodenal Ulcer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, YH; Masago, K; Mishima, M1
Argiris, A; Basu, S; Bonomi, P; Buckingham, L; Coon, J; Fidler, MJ; Johnson, DH; Kaiser, K; Patel, JD; Sandler, A; Villaflor, VM1

Trials

1 trial(s) available for erlotinib hydrochloride and Gastroduodenal Ulcer

ArticleYear
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Apr-01, Volume: 14, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Celecoxib; Cyclooxygenase 2; Disease-Free Survival; ErbB Receptors; Erlotinib Hydrochloride; Female; Gastrointestinal Hemorrhage; Humans; Immunohistochemistry; In Situ Hybridization; Kaplan-Meier Estimate; Lung Neoplasms; Male; Mutation; Peptic Ulcer; Predictive Value of Tests; Pyrazoles; Quinazolines; Sulfonamides

2008

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Gastroduodenal Ulcer

ArticleYear
Erlotinib and gastrointestinal ulcer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:7

    Topics: Aged; ErbB Receptors; Erlotinib Hydrochloride; Female; Gastrointestinal Diseases; Humans; Male; Peptic Ulcer; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome

2010